Coeptis Therapeutics Holdings, Inc. Warrants (COEPW)

• Market cap: $101K
• 1 day: 24.48%
• 5 days: -14.04%
• 1 month: -9.64%
• 3 months: 25.00%
• 6 months: 30.43%
• Year to date: -16.20%
• 1 year: 72.41%
• 5 years: -95.00%
• 10 years: -95.00%
• Sector: Healthcare
• Industry: Biotechnology

About: Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Employees: 7

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

142% more capital invested

Capital invested by funds: $9.72K [Q1] → $23.5K (+$13.8K) [Q2]

23.34% more ownership

Funds ownership: 2.06% [Q1] → 25.4% (+23.34%) [Q2]

8% less funds holding

Funds holding: 13 [Q1] → 12 (-1) [Q2]

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3